PTEN is a negative regulator of intracellular phosphatidylinositol triphosphate levels, and is the main negative regulator of the PI3K/AKT/mTOR signal transduction pathway, which is typically downregulated in breast cancer 26,27. This evidence concerns the gene MTOR and breast carcinoma.